Rating Change
Piper Sandler analysts reiterated a Overweight rating on Inovio Pharmaceuticals, Inc. (NASDAQ:INO) on August 03, 2026.
reiterateNASDAQ:INO
Piper Sandler Reiterates Overweight Rating on Inovio Pharmaceuticals, Inc. (INO)
Rating Change Piper Sandler analysts reiterated a Overweight rating on Inovio Pharmaceuticals, Inc. (NASDAQ:INO) on August 03, 2026. Market Context Inovio Pharmaceuticals, Inc.
Market Context
Inovio Pharmaceuticals, Inc. operates in the Healthcare sector. The stock currently trades at $0.70 with a market capitalization of $114.7M. The stock has declined 53.6% over the past 52 weeks.
Analyst coverage from Piper Sandler provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Inovio Pharmaceuticals, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Inovio Pharmaceuticals, Inc.
Among the 10 most recent ratings: 5 Buy, 5 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 03, 2026 | Piper Sandler | Overweight | N/A |
| Jun 01, 2026 | HC Wainwright & Co. | Neutral | N/A |
| Nov 14, 2025 | Piper Sandler | Overweight | N/A |
| Aug 14, 2025 | HC Wainwright & Co. | Neutral | N/A |
| Jul 09, 2025 | Piper Sandler | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View INO Stock Page
Frequently Asked Questions
What does a Overweight rating mean for INO?
A Overweight rating from Piper Sandler reflects the analyst's outlook on Inovio Pharmaceuticals, Inc. (NASDAQ:INO). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the INO forecast page.